C-Suite
Experienced in filling C-Suite roles across Life Sciences
Specialists in Recruiting C-Suite Talent
Pharmaceutical and biotech firms of all sizes are seeking senior and C-suite roles. We’re passionate about supporting high-level and ambitious talent to secure leadership roles with cutting-edge companies.The demand for C-suite recruitment solutions has kept pace as investment in the healthcare and life sciences sector ramped up in 2021 and 2022.
Companies in all life sciences sectors will require strong leadership as they navigate the choppy economic waters forecasted for 2023—with Deloitte reporting that inflation will significantly impact medical technologies and healthcare organisations as the year progresses.
Big data and machine learning developments are also driving innovation, with C-suite roles such as Chief Digital Officer becoming more recognisable as businesses leverage candidates’ tech expertise.
Warman O’Brien recognises that leadership has transformed due to the disruptions to the world over the COVID-19 pandemic. C-suite roles are pivotal in ensuring the future-proofing of a company—with the values of transparency and innovation at the executive level leading to energy and agility at all organisational levels.
Drop off your CV
Ready for your next career move? Please drop off your CV here; our team will contact you to bring a tailored selection of jobs that suit you the best.
C-Suite Jobs are the Key to Company Success
With the increased pressure of financial instability and staffing issues—a result of the pandemic and geopolitics in the former case, and the skills gap in the latter—8 out of every 10 C-suite executives in the healthcare and biopharma sectors say that they’ll experience some struggles in 2023. Therefore, a big focus for those filling the C-suite jobs of the present and future will be organisational resiliency and ensuring that the best talent is getting through the hiring process and filling vacancies.
As a specialist in C-suite recruitment for the life sciences sector, Warman O’Brien recognises that executives seek to empower frontline workers. This will enable them to, in turn, deliver strong annual growth when compared to their counterparts tethered to traditional ways of working. As a result, the executive teams of global organisations are implementing options that allow their staff to balance their home and working lives while still being able to collaborate with their colleagues.
C-Suite Level Positions in all Life Sciences Fields
As a specialist life sciences recruiter, Warman O’Brien knows the challenges facing today’s business leaders. We offer our clients and candidates lifelong support as they search for C-suite roles. Our consultants are experts in the various fields of life sciences and can support candidates as they apply for executive C-suite level positions with often niche requirements.
Chief Executive Officer
Chief Executive Officer is responsible for managing their organisations according to the instruction of their board of directors. These professionals are tasked with facilitating and achieving the long-term goals and vision of the business and are ultimately responsible for the success of any strategic corporate decisions.
Chief Operations Officer
The Chief Operations Officer is tasked with ensuring the daily operations of a life science business run smoothly, working in close partnership with the chief executive officer. As organisations in the pharmaceutical, biotechnology and medical device sectors become larger and their day-to-day activities become more complex, the COO is responsible for diverse duties. However, these are focused on driving performance and productivity across their entire workforce.
Chief Technology Officer
Guiding and facilitating technological innovation in their businesses, the chief technology officer is responsible for finding scalable tools to enable their organisations to solve problems and leverage analytics to guide their operations. As a recruitment partner for cutting-edge global pharma and biotech businesses, we know the challenges the CTO will face and are prepared to support these talented candidates.
Chief Scientist Officer
Warman O’Brien recognises the Chief Scientific Officer's significance, the experience required to direct medicine's future, and the therapies that will help us address health challenges. Our specialist recruiters are ready to assist in the search for your next C-suite-level position. As pressure mounts on organisations in the life sciences sector to produce new vaccines, devices, and personalised medicines, the role of the CSO has never been more critical.
Chief Medical Officer
Experts on all matters of health, clinical oversight and patient safety, the Chief Medical Officer is an integral member of the c-suite team. They help guide the long-term vision for their company's products and services, reduce exposure to risk, and ensure compliance with industry and government regulations. The CMO is responsible for supporting the scale-up activities of the organisations they work for, ensuring sustainable and safe growth.
Meet the C-Suite Employment Team
Warman O’Brien’s C-suite recruitment team are life sciences executive search specialists. This enables candidates to find C-suite jobs with some of the most exciting organisations worldwide in biotech, pharmaceuticals and contract research.
Success stories
At Warman O’Brien, we’re pleased to support the operations and data science needs of contract research organisations and leading biotech and pharmaceutical organisations across the globe.
To learn more about our experience sourcing executive talent, please see our recent case studies, where we explore the complex requirements needed to secure talented candidates for niche roles in this field.
Services We Provide:
We provide a number of services to support the appointment of c-suite professionals within the life sciences sector, including:
- Retained executive search and c-suite recruitment across all life sciences sectors
- Leadership consultancy and advisory
- Team builds, enabling organisations to create a “fully blended” corporate management team
- Board evaluations
- Internal and external benchmarking
